Alkem unit updates Occlutech acquisition deal with supplementary agreement

Listed Co AcquisitionStrategic Transactions View source PDF Explain this filing

ALKEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.2%Reaction day

₹5425.00

prior close

₹5507.00

announcement price

In-mkt

timing

Nifty Midcap 150market-0.3%+0.5% vs market

Pharmaceuticals peers, median of 165sector+0.1%+0.1% vs sector

On the reaction day the stock moved 0.5 pts more than Nifty Midcap 150 and 0.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

+0.3

15m

+0.2

30m

-0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.2-0.3+0.5+0.1+0.1

Next day

+2.8+0.1+2.7+0.9+1.8

+2.5+0.3+2.2+0.3+2.2

+1.4+0.8+0.6+0.8+0.6

+2.8+0.6+2.2+1.7+1.1

+3.2+1.0+2.2+1.5+1.7

+3.6-0.9+4.5+0.1+3.5

15d

+4.2+1.5+2.7+1.8+2.4

+4.8+1.6+3.2+1.6+3.3

-1.8+3.5-5.2+1.3-3.1

-3.2-3.9+0.7+4.8-8.1

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Alkem Laboratories' wholly owned subsidiary Alkem Medtech has signed a First Supplementary Agreement on 26 June 2026 to its earlier Share Purchase Agreement for acquiring 51 percent to 55 percent stake in Switzerland-based Occlutech Holding AG. This amends the original deal signed on 6 March 2026, which was first disclosed to exchanges in February 2026. Occlutech operates in the medtech segment. Further details will be posted on the company's website.

Likely market impact

Progression of the medtech acquisition shows Alkem continuing its international expansion; terms of the deal have now been amended.